Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

123 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Comparison of new prognostic systems for patients with resectable hepatocellular carcinoma: Albumin-Bilirubin grade and Albumin-Indocyanine Green Evaluation grade.
Honmyo N, Kobayashi T, Hamaoka M, Kohashi T, Abe T, Oishi K, Tazawa H, Imaoka Y, Akita T, Tanaka J, Ohdan H; Hiroshima Surgical study group of Clinical Oncology (HiSCO). Honmyo N, et al. Among authors: imaoka y. Hepatol Res. 2019 Oct;49(10):1218-1226. doi: 10.1111/hepr.13393. Epub 2019 Jul 10. Hepatol Res. 2019. PMID: 31237074
Laparoscopic versus open limited liver resection for hepatocellular carcinoma with liver cirrhosis: a propensity score matching study with the Hiroshima Surgical study group of Clinical Oncology (HiSCO).
Yamamoto M, Kobayashi T, Oshita A, Abe T, Kohashi T, Onoe T, Fukuda S, Omori I, Imaoka Y, Honmyo N, Ohdan H. Yamamoto M, et al. Among authors: imaoka y. Surg Endosc. 2020 Nov;34(11):5055-5061. doi: 10.1007/s00464-019-07302-y. Epub 2019 Dec 11. Surg Endosc. 2020. PMID: 31828498
A novel model for predicting posthepatectomy liver failure based on liver function and degree of liver resection in patients with hepatocellular carcinoma.
Honmyo N, Kobayashi T, Kuroda S, Oshita A, Onoe T, Kohashi T, Fukuda S, Ohmori I, Abe T, Imaoka Y, Akita T, Tanaka J, Ohdan H. Honmyo N, et al. Among authors: imaoka y. HPB (Oxford). 2021 Jan;23(1):134-143. doi: 10.1016/j.hpb.2020.05.008. Epub 2020 Jun 18. HPB (Oxford). 2021. PMID: 32563594 Free article.
A multicenter randomized controlled trial comparing administration of antithrombin III after liver resection (HiSCO-05 trial).
Kuroda S, Kobayashi T, Tashiro H, Onoe T, Oshita A, Abe T, Kohashi T, Oishi K, Ohmori I, Imaoka Y, Tanaka J, Ohdan H; Hiroshima Surgical Study Group of Clinical Oncology. Kuroda S, et al. Among authors: imaoka y. Surgery. 2021 Oct;170(4):1140-1150. doi: 10.1016/j.surg.2021.03.057. Epub 2021 Apr 27. Surgery. 2021. PMID: 33926704 Clinical Trial.
Liver resection is associated with good outcomes for hepatocellular carcinoma patients beyond the Barcelona Clinic Liver Cancer criteria: A multicenter study with the Hiroshima Surgical study group of Clinical Oncology.
Yamamoto M, Kobayashi T, Honmyo N, Oshita A, Abe T, Kohashi T, Onoe T, Fukuda S, Omori I, Imaoka Y, Ohdan H. Yamamoto M, et al. Among authors: imaoka y. Surgery. 2022 May;171(5):1303-1310. doi: 10.1016/j.surg.2021.09.009. Epub 2021 Oct 30. Surgery. 2022. PMID: 34756748
Predictors of tolerability for postoperative adjuvant S1 plus docetaxel chemotherapy for gastric cancer: a multicenter retrospective study.
Toyota K, Tanabe K, Kano M, Komo T, Hotta R, Yanagawa S, Saeki Y, Tazawa H, Ikeda M, Shishida M, Okano K, Ide R, Imaoka Y, Takahashi S, Ohdan H; Hiroshima Surgical Study Group of Clinical Oncology (HiSCO). Toyota K, et al. Among authors: imaoka y. Gastric Cancer. 2024 Nov 9. doi: 10.1007/s10120-024-01563-w. Online ahead of print. Gastric Cancer. 2024. PMID: 39520590
123 results